Imatinibe mesilato no Brasil Imatinibe mesylate in Brazil

Imatinibe mesilato no Brasil Imatinibe mesylate in Brazil

Bibliographic Details
Main Author:	Marcos Lima
Format:	Article
Language:	English
Published:	Elsevier 2005-09-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842005000300001

Similar Items

O tratamento da Leucemia Mielóide Crônica com mesilato de imatinibe Therapy of Chronic Myeloid Leukemia with imatinib mesylate
by: Vaneuza M. Funke, et al.
Published: (2008-04-01)

Therapy of chronic myeloid leukemia with imatinib mesylate in Brazil: a study of 98 cases Tratamento da leucemia mielóide crônica com imatinib mesilato no Brasil: estudo de 98 casos
by: Vaneuza A. M. Funke, et al.
Published: (2005-09-01)

Falla cardiaca asociada con el uso de imatinib mesilato: Reporte de un caso Heart failure associated to imatinib mesylate use: Case report
by: Clara Saldarriaga, et al.
Published: (2008-12-01)

Imatinib mesylate-induced palmoplantar keratoderma
by: Niharika Jha, et al.
Published: (2021-01-01)

Periorbital edema secondary to imatinib mesylate
by: Collin M McClelland, et al.
Published: (2010-05-01)

Effect of astaxanthin in imatinib mesylate-induced cardiotoxicity
by: İshak Suat Övey, et al.
Published: (2020-03-01)

Mutations Associated with Imatinib Mesylate Resistance - Review
by: Linev Alexandar J., et al.
Published: (2018-12-01)

The teratogenic effects of imatinib mesylate on rat fetuses
by: M.M. El Gendy, et al.
Published: (2015-01-01)

Análise de pacientes com leucemia mieloide crônica com resistência primária ou secundária ao mesilato de imatinibe Analysis of chronic myelogenous leukemia patients with primary or secondary resistance to imatinib mesylate
by: Rita de Cássia S. Alves
Published: (2009-01-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate
by: Bożena Karolewicz, et al.
Published: (2019-07-01)

The role of c-kit and imatinib mesylate in uveal melanoma
by: Pereira Patricia, et al.
Published: (2005-10-01)

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
by: Omar S Din, et al.
Published: (2008-03-01)

Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
by: Alexandra Rodrigues Alves, et al.

ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor.
by: Lori Rink, et al.
Published: (2013-01-01)

Generalized lichenoid drug eruption associated with imatinib mesylate therapy
by: Sudip Kumar Ghosh
Published: (2013-01-01)

OUR EXPERIENCE WITH TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Mojca Modic, et al.
Published: (2004-12-01)

Anti-Diabetic and Beta-Cell Protective Actions of Imatinib Mesylate
by: Hägerkvist, Robert
Published: (2006)

OUR EXPERIENCE IN TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Marjana Glaser, et al.
Published: (2004-04-01)

Análise do mesilato de imatinibe em plasma empregando a eletroforese capilar
by: Tatiana Okura Ajimura
Published: (2010)

Análise do mesilato de imatinibe em plasma empregando a eletroforese capilar
by: Ajimura, Tatiana Okura
Published: (2010)

Acompanhamento farmacoterapêutico dos pacientes com leucemia mieloide crônica em uso de mesilato de imatinibe na Universidade Federal do Ceará The pharmacotherapeutic follow- up of patients with chronic myeloid leukemia (CML) on imatinib mesylate therapy
by: Sterfen S. Aquino, et al.
Published: (2009-01-01)

Leucemia Mielóide Crônica: causas de falha do tratamento com mesilato de imatinibe Chronic Myeloid Leukemia: causes of treatment failure with imatinib
by: Katia B. B. Pagnano
Published: (2008-04-01)

Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1
by: Ken‐ichi Yasuda, et al.
Published: (2020-11-01)

Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
by: Vijay Gandhi Linga, et al.
Published: (2014-01-01)

Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants
by: Gholamreza Azizi, et al.
Published: (2014-06-01)

Hypopigmentation of the skin due to imatinib mesylate in patients with chronic myeloid leukemia
by: Aamer Aleem
Published: (2009-04-01)

Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.
by: Zheng Hu, et al.
Published: (2009-01-01)

Optimal Duration of Imatinib Mesylate Therapy in Metastatic Gastrointestinal Stromal Tumours
by: Ruth Gauden, et al.
Published: (2011-04-01)

Imatinib mesylate-induced cutaneous rash masquerading as pityriasis rosea of Gilbert
by: Prashant Verma, et al.
Published: (2014-01-01)

Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia
by: G.A.P. Oliveira, et al.
Published: (2010-06-01)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
by: Sumin Tang, et al.
Published: (2017-04-01)

A case of pediatric cutaneous mastocytosis successfully treated with imatinib mesylate
by: Rameshwar Gutte, et al.
Published: (2017-01-01)

Molecular response to imatinib mesylate of Brazilian patients with chronic myeloid leukemia
by: Ana Lucia Vieira-Mion, et al.

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
by: Weigel Marion T, et al.
Published: (2010-08-01)

A rare complication of imatinib mesylate therapy: drug-induced pneumonitis
by: Ol'ga Veniaminovna Stakhina, et al.
Published: (2010-02-01)

O papel da hibridação in situ por fluorescência (FISH) na leucemia mielóide crônica durante o tratamento com mesilato de imatinibe The role of fluorescent in situ hybridization (FISH) in monitoring chronic myeloid leukemia during treatment with imatinib mesylate
by: Monika C. R. Mello
Published: (2006-06-01)

Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
by: Doran Ksienski
Published: (2011-11-01)

Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
by: Doran Ksienski
Published: (2011-01-01)